News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BISARO PAUL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| BISARO PAUL (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Paid exercise price by delivering 3,689 shares
@ $1.28, valued at
$4.7k
Disposed/sold 39,083 shares
@ $0 |
|
| 06/02/2023 |
4
| BISARO PAUL (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 7,575 shares
@ $0 |
|
| 03/16/2023 |
4
| BISARO PAUL (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Bought 5,000 shares
@ $8.4659, valued at
$42.3k
|
|
| 02/14/2023 |
4
| BISARO PAUL (Director) has filed a Form 4 on Zoetis Inc.|
Txns:
| Exercised 1,627 options to buy
@ $0 |
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/03/2022 |
4
| BISARO PAUL (Director) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 5,000 restricted stock units
@ $0 |
|
| 09/14/2022 |
4
| BISARO PAUL (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Disposed/sold 44,354 restricted stock units
@ $0 |
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| BISARO PAUL (Director) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 96,864 restricted stock units
@ $0 |
|
| 06/08/2020 |
4
| BISARO PAUL (Director) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Bought 50,000 shares
@ $1.14, valued at
$57k
|
|
| 03/26/2020 |
3
| BISARO PAUL (Director) has filed a Form 3 on TherapeuticsMD, Inc. |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2019 |
4
| BISARO PAUL (Executive Chairman) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 12,529 shares
@ $13.44, valued at
$168.4k
Exercised 24,983 restricted stock units
@ $0 |
|
| 03/12/2019 |
4
| BISARO PAUL (Executive Chairman) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Bought 17,000 shares
@ $11.97, valued at
$203.5k
|
|
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2018 |
4
| BISARO PAUL (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 850,000 options
@ $12.7, valued at
$10.8M
Granted 408,719 options
@ $15.01, valued at
$6.1M
Granted 99,933 restricted stock units
@ $0 |
|
| 05/08/2018 |
3
| BISARO PAUL (Director) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 05/08/2018 |
4
| BISARO PAUL (President and CEO) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 850,000 options to buy
@ $12.7, valued at
$10.8M
|
|
| 05/04/2018 |
4
| BISARO PAUL (Director) has filed a Form 4 on Allergan plc|
Txns:
| Granted 1,985 shares
@ $151.07, valued at
$299.9k
|
|
|
|
|